retatrutide clinical trial malaysia Results: 28.3% Weight Loss Data Retatrutide UK 2026: Phase 3
Description
Rapid Weight Loss Rapid weight reduction is one of the most common triggers of telogen effluvium

But it's not simply about eating less

Perioperative GLP-1 RA therapy was linked with a statistically significant and durable reduction in pseudoarthrosis risk at all evaluated time points (Table 1): In addition to improved fusion outcomes, GLP-1 RA use was linked to fewer early postoperative complications

A post-treatment analysis from 2024 found that keeping up with exercise after stopping GLP-1 receptor agonists was associated with less weight regain
PlexusDx patients receive detailed guidance on managing this response and determining whether adjustments are needed
To learn more about the role of telehealth and ordering support, our guide to ordering GLP-1 medications explains the process in more detail
